|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Inter-Medic Medical Group, North Port, FL (LSG); the Department of Family Medicine, University Hospitals of Cleveland, Case Western Reserve University (LL); the Centers for Disease Control and Prevention, Atlanta (ESF); the Division of Preventive Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston (SL); and the Department of Epidemiology, Harvard School of Public Health, Boston (SL).
2 Supported by a CI-8 Clinical Investigator Award from Damon Runyon Cancer Research Foundation (to LL).
3 Address reprint requests to LS Gross, Inter-Medic Medical Group, 2630 Bobcat Village Center Road, North Port, FL 34288. E-mail: leegross{at}msn.com.
See corresponding editorial on page 711.
| ABSTRACT |
|---|
|
|
|---|
Objective: The objective was to examine the correlation between consumption of refined carbohydrates and the prevalence of type 2 diabetes in the United States.
Methods: In this ecologic correlation study, the per capita nutrient consumption in the United States between 1909 and 1997 obtained from the US Department of Agriculture was compared with the prevalence of type 2 diabetes obtained from the Centers for Disease Control and Prevention.
Results: In a univariate analysis, a significant correlation with diabetes prevalence was observed for dietary fat (r = 0.84, P < 0.001), carbohydrate (r = 0.55, P < 0.001), protein (r = 0.71, P < 0.001), fiber (r = 0.16, P = 0.03), corn syrup (r = 0.83, P < 0.001), and total energy (r = 0.75, P < 0.001) intakes. In a multivariate nutrient-density model, in which total energy intake was accounted for, corn syrup was positively associated with the prevalence of type 2 diabetes (ß = 0.0132, P = 0.038). Fiber (ß = 13.86, P < 0.01) was negatively associated with the prevalence of type 2 diabetes. In contrast, protein (P = 0.084) and fat (P = 0.79) were not associated with the prevalence of type 2 diabetes when total energy was controlled for.
Conclusions: Increasing intakes of refined carbohydrate (corn syrup) concomitant with decreasing intakes of fiber paralleled the upward trend in the prevalence of type 2 diabetes observed in the United States during the 20th century.
Key Words: Type 2 diabetes obesity dietary fiber refined carbohydrate dietary carbohydrate glycemic index
| INTRODUCTION |
|---|
|
|
|---|
The cause of type 2 diabetes is multifactorial. Factors such as changes in exercise patterns and the ethnic composition of the US population are likely contributors to the rising trends in diabetes, but there have been many debates in the scientific literature about the effects of specific dietary macronutrients on the risk of obesity and type 2 diabetes (9-12). Recent data suggest that a high intake of refined carbohydrates may increase the risk of insulin resistance (13-16). Although an increase in the intake of refined carbohydrates in the form of processed grains, soft drinks, sweeteners, and refined flours in the US food supply has been reported, scant quantitative data exist to determine whether such changes in dietary composition are related to the current epidemic of obesity and type 2 diabetes in the United States. To address this issue, we examined almost one century of dietary data and the history behind changes in the US diet. We conducted a multivariate analysis of the correlation between changes in the prevalence of type 2 diabetes and changes in dietary patterns in the United States.
| METHODS |
|---|
|
|
|---|
The prevalence of obesity was based on the measured height and weight of a random sample of the civilian noninstitutionalized population aged
20 y, and is reported as a percentage of the US population with a body mass index (BMI; kg/m2) of
30. The data came from the National Health Examination Survey (NHES 19601962); the first, second, and third National Health and Nutrition Examination Surveys (NHANES I, 19711974; NHANES II, 19761980; NHANES III, 19881994); and NHANES 1999.
Unless stated otherwise, the nutrient content of the US food supply and other nutrition data were obtained from the National Nutrient Data Bank, which is maintained by the Center for Nutrition Policy and Promotion and the Economic Research Service of the US Department of Agriculture (20). Nutrient data are based on food disappearance and were calculated with the use of food availability data from the Economic Research Service and on the basis of the nutrient content of the edible portion of the available food supply as calculated by the Nutrient Data Laboratory of the Agricultural Research Service. These food-composition data are the numerical foundation of essentially all public and private work in the field of human nutrition (20).
Regression analysis was performed to examine the correlation between macronutrient consumption and disease rates. A multivariate nutrient-density model was used to control for total energy intake (21). In particular, corn syrup was selected to represent refined carbohydrates in the model, because it is a highly refined substance that is consumed in vast quantities in the United States in the form of soft drinks, commercial baked goods, ready-to-eat breakfast cereals, and many other commercially processed food products. Similarly, dietary fiber was selected because it generally is removed during the refining process. All P values are two sided. The statistical analysis was performed with the use of EPI-INFO (2002; Centers for Disease Control and Prevention, Atlanta).
| RESULTS |
|---|
|
|
|---|
|
In a multivariate nutrient-density model (Table 1
)in which total energy, corn syrup, fiber, fat, and protein intakes were simultaneously includedcorn syrup was positively associated with the prevalence of type 2 diabetes (ß = 0.0132, P = 0.038), whereas dietary fiber (ß = 13.86, P < 0.01) was negatively associated with the prevalence of type 2 diabetes. In contrast, the percentages of energy from protein (P = 0.083) and fat (P = 0.79) were not associated with the prevalence of type 2 diabetes after adjustment for total energy intake and other dietary variables in the multivariate nutrient-density model.
|
The total per capita use of caloric sweeteners increased by 86% between 1909 and 1997, and the type of sweeteners used also changed dramatically. Corn syrup sweeteners, which were almost nonexistent at the beginning of the century, now comprise > 20% of the total daily carbohydrate intake and 10% of the daily total energy intake, which represents an increase of > 2100%. These sweeteners have surpassed sucrose as the leading sweetener in the US food industry and account for much of the rebound increase in carbohydrate consumption after the mid-1960s, largely replacing the losses due to whole grains (Figure 2
). There was a significant correlation between the percentage of carbohydrate from corn syrup and the prevalence of type 2 diabetes (r = 0.85, P < 0.001; Figure 3
).
|
|
| DISCUSSION |
|---|
|
|
|---|
|
|
Corn refining in the United States began around the time of the Civil War with the development of cornstarch (25). In 1866, it was discovered that cornstarch could be converted to glucose, and by 1882 the corn industry was manufacturing "refined corn sugar." The remainder of the corn plant (fiber, germ, and protein) that was removed in the refining process was sold for animal feed or for the conversion to corn oil. Corn syrup technology advanced significantly with the introduction of enzyme-hydrolyzed products. In 1921, crystalline dextrose hydrate was introduced. The purification and crystallization of glucose meant that, for the first time, corn-based sweeteners could compete in some markets that had been the sole domain of the sugar industry. In the mid-1950s, the technology for commercially preparing low-conversion products such as maltodextrin syrup was developed. The next development involved the enzyme-catalyzed isomerization of glucose to fructose. The commercial production of high-fructose corn syrup (HFCS) began in 1967, at which time the fructose content of the syrup was
15%. Further research enabled the industry to develop a higher-conversion HFCS that had a fructose content of 42%. After a few more modifications, an HFCS with a fructose content of 55% became the sweetener of choice for the soft drink and ice cream industries, and an HFCS with a fructose content of 90% became a frequent choice for use in "natural" and "light" foods. By 2002, HFCS sweeteners represented > 56% of the US nutritive sweetener market.
The results of this ecologic study need to be interpreted in the context of the studys strengths and weaknesses. Ecologic studies, such as observational studies of individual persons, are susceptible to confounding. The so-called ecologic fallacy may occur when inferences are made about individual persons on the basis of solely population-level data. Our analysis may also have been limited by the use of food disappearance data at the population level that are indirectly related to intakes at individual levels. To address these issues, our analyses used only population-level variables (energy from macronutrients) to predict the only ecologic outcome (population-level prevalence of type 2 diabetes). Because we avoided inferences about individual persons from population data, no cross-level bias should occur (26, 27). Also, because we applied food disappearance data only from within the United States and did not compare regional, international, or ethnic group data, the bias, if any, would at least be uniform for the same population. Although food disappearance data are an indirect measure of individual consumption, these data have been calculated annually for more than a century, making them the only consistent data available for identifying secular trends (22).
To establish a causal diet-disease relation, however, one must examine evidence from a variety of sources and look for congruence between these sources (28). This is especially important when interpreting population-level analyses of macronutrient intakes because the specific effects of individual macronutrients and the generic effect of total energy intakes may not be evident in individual-based studies with small sample sizes (29, 30). To this end, such ecologic studies have advantages over population-based interventions for identifying potential diet-disease relations (24).
Changes in diagnostic criteria and screening practices for type 2 diabetes may limit the ability to determine the extent of effect due solely to dietary changes. To reduce this bias, we excluded data beyond 1997. Although prevalence data from the National Health Interview Survey are self-reported, many studies have indicated excellent agreement between self-reported data and data from medical records concerning a persons diabetes status (31-35). The issue of confounding with obesity, physical activity, or both is challenging. Unfortunately, there is no uniform source of consistent information about physical activity in the United States for the period studied. The Behavioral Risk Factor Surveillance Survey has only produced such data since the 1990s (36). Similarly, the first national obesity data were from the early 1960s, which provide only 5 usable data points from the National Health Examination Survey and NHANES studies since that time. Use of such scant data to control for obesity would lack sufficient power to be meaningful. However, because obesity is likely an intermediary for the development of type 2 diabetes, control for this variable would likely negate the contribution of any macronutrient. Thus, the control for obesity may be a case of overadjustment. These potential confounders will hopefully be teased out by future prospective studies.
Classifying foods according to the physiologic effects obtained directly from metabolic experiments is useful in understanding the health effects of diets (37). Indeed, the concept that carbohydrates vary in quality is not new (ie, carrots are not the same as cake) and appears to have important clinical significance. The glycemic index (GI) is a relative in vivo measure of the plasma glucose response to a standardized amount of carbohydrate. The glycemic load (GL) is a product of the GI and the total amount of carbohydrate consumed, incorporating the effects of both the quality and quantity of carbohydrate intake. A growing body of evidence suggests that a high dietary GL increases the risk of obesity, glucose intolerance, dyslipidemia, type 2 diabetes, and coronary heart disease (38-49).
In several small-scale metabolic trials, refined grains have been shown to cause a significant increase in insulin secretion and the postprandial glucose response (50-54). In general, substituting high-fiber, low-GI foods for high-GI foods significantly improves fasting insulin concentrations, the postprandial insulin response, glycemic control, and lipid profiles (55-65). Corn syrup largely consists of the monosaccharide fructose, in contrast with sucrosewhich is a disaccharide of fructose and glucose. Fructose, unlike sucrose, has been directly linked to insulin resistance in small human and animal studies and has been implicated in every metabolic abnormality associated with the metabolic syndrome (66-69). Corn syrup is now endemic in the US food supply, which places an unprecedented biochemical evolutionary pressure for processing fructose.
Several prospective cohorts have incorporated the concept of GI in assessing the relations between dietary carbohydrate and the risk of type 2 diabetes. In the Nurses Health Study, the multivariate-adjusted relative risk of type 2 diabetes during 6 y of follow-up was 1.37 (95% CI: 1.09, 1.71) for an increase in GI of 15 units and was 1.47 (95% CI: 1.16, 1.86) for extreme quintiles of dietary GL. Women with both a high dietary GL and a low cereal fiber intake were at an even higher risk of type 2 diabetes (relative risk: 2.43; 95% CI: 1.12, 5.27) (70). In the Health Professionals Follow-up Study, the multivariate-adjusted relative risk was 1.37 (95% CI: 1.02, 1.83) in 6 y of follow-up for extreme quintiles of dietary GL and 2.17 (95% CI: 1.04, 4.54) for the combination of a high GL and a low intake of cereal fiber (71). In the Iowa Womens Health Study, however, neither the GI nor the GL were related to the risk of type 2 diabetes in 6 y of follow-up, although dietary fructose and glucose were significantly associated with increased risk (72).
Our analysis confirmed that during the past century, especially the past 20 y, the American diet has undergone a dramatic change. Furthermore, our data indicate that, during the same period, type 2 diabetes has reached epidemic proportions, exerting a substantial health burden on society. These population-level data are consistent with findings from metabolic and prospective studies of individual persons, which suggest that the intake of refined carbohydrates increases the risk of obesity, glucose intolerance, dyslipidemia, and type 2 diabetes. The risk of type 2 diabetes may be reduced by replacing refined carbohydrates with low-GI carbohydrate sources and whole-grain, high-fiber products. Further prospective randomized trials are necessary to determine the absolute effect of such an intervention.
|
| ACKNOWLEDGMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
Related articles in AJCN:
This article has been cited by other articles:
![]() |
C N Lopez, M A Martinez-Gonzalez, A Sanchez-Villegas, A Alonso, A M Pimenta, and M Bes-Rastrollo Costs of Mediterranean and western dietary patterns in a Spanish cohort and their relationship with prospective weight change J Epidemiol Community Health, November 1, 2009; 63(11): 920 - 927. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Imamura, A. H Lichtenstein, G. E Dallal, J. B Meigs, and P. F Jacques Generalizability of dietary patterns associated with incidence of type 2 diabetes mellitus Am. J. Clinical Nutrition, October 1, 2009; 90(4): 1075 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Johnson, L. J. Appel, M. Brands, B. V. Howard, M. Lefevre, R. H. Lustig, F. Sacks, L. M. Steffen, J. Wylie-Rosett, and on behalf of the American Heart Association Nutrit Dietary Sugars Intake and Cardiovascular Health: A Scientific Statement From the American Heart Association Circulation, September 15, 2009; 120(11): 1011 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Manders, B. Pennings, C. P. Beckers, T. I Aipassa, and L. J. van Loon Prevalence of daily hyperglycemia in obese type 2 diabetic men compared with that in lean and obese normoglycemic men: effect of consumption of a sucrose-containing beverage Am. J. Clinical Nutrition, September 1, 2009; 90(3): 511 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Johnson, S. E. Perez-Pozo, Y. Y. Sautin, J. Manitius, L. G. Sanchez-Lozada, D. I. Feig, M. Shafiu, M. Segal, R. J. Glassock, M. Shimada, et al. Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes? Endocr. Rev., February 1, 2009; 30(1): 96 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Yeh, A. Viladrich, N. Bruning, and C. Roye Determinants of Latina Obesity in the United States: The Role of Selective Acculturation J Transcult Nurs, January 1, 2009; 20(1): 105 - 115. [Abstract] [PDF] |
||||
![]() |
J. S White Straight talk about high-fructose corn syrup: what it is and what it ain't Am. J. Clinical Nutrition, December 1, 2008; 88(6): 1716S - 1721S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Rosenzweig, E. Ferrannini, S. M. Grundy, S. M. Haffner, R. J. Heine, E. S. Horton, and R. Kawamori Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3671 - 3689. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Douard and R. P. Ferraris Regulation of the fructose transporter GLUT5 in health and disease Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E227 - E237. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Douard, H.-I. Choi, S. Elshenawy, D. Lagunoff, and R. P. Ferraris Developmental reprogramming of rat GLUT5 requires glucocorticoid receptor translocation to the nucleus J. Physiol., August 1, 2008; 586(15): 3657 - 3673. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Feinglos and S. E. Totten Are You What You Eat, or How Much You Eat?: The Case of Type 2 Diabetes Mellitus Arch Intern Med, July 28, 2008; 168(14): 1485 - 1486. [Full Text] [PDF] |
||||
![]() |
S. Kirchner, A. Muduli, D. Casirola, K. Prum, V. Douard, and R. P Ferraris Luminal fructose inhibits rat intestinal sodium-phosphate cotransporter gene expression and phosphate uptake Am. J. Clinical Nutrition, April 1, 2008; 87(4): 1028 - 1038. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K Choi and G. Curhan Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study BMJ, February 9, 2008; 336(7639): 309 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Douard, X.-L. Cui, P. Soteropoulos, and R. P. Ferraris Dexamethasone Sensitizes the Neonatal Intestine to Fructose Induction of Intestinal Fructose Transporter (Slc2A5) Function Endocrinology, January 1, 2008; 149(1): 409 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N Davis, K. E Alexander, E. E Ventura, L. A Kelly, C. J Lane, C. E Byrd-Williams, C. M Toledo-Corral, C. K Roberts, D. Spruijt-Metz, M. J Weigensberg, et al. Associations of dietary sugar and glycemic index with adiposity and insulin dynamics in overweight Latino youth Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1331 - 1338. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Akhavan and G H. Anderson Effects of glucose-to-fructose ratios in solutions on subjective satiety, food intake, and satiety hormones in young men Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1354 - 1363. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Monsivais, M. M Perrigue, and A. Drewnowski Sugars and satiety: does the type of sweetener make a difference? Am. J. Clinical Nutrition, July 1, 2007; 86(1): 116 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Drewnowski The Real Contribution of Added Sugars and Fats to Obesity Epidemiol. Rev., June 24, 2007; (2007) mxm011v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B Mellen, A. D Liese, J. A Tooze, M. Z Vitolins, L. E Wagenknecht, and D. M Herrington Whole-grain intake and carotid artery atherosclerosis in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1495 - 1502. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Huang, N. Dedousis, and R. M. O'Doherty Hepatic steatosis and plasma dyslipidemia induced by a high-sucrose diet are corrected by an acute leptin infusion J Appl Physiol, June 1, 2007; 102(6): 2260 - 2265. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Drewnowski and F. Bellisle Liquid calories, sugar, and body weight Am. J. Clinical Nutrition, March 1, 2007; 85(3): 651 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liu Lowering dietary glycemic load for weight control and cardiovascular health: a matter of quality. Arch Intern Med, July 24, 2006; 166(14): 1438 - 1439. [Full Text] [PDF] |
||||
![]() |
J. McMillan-Price, P. Petocz, F. Atkinson, K. O'Neill, S. Samman, K. Steinbeck, I. Caterson, and J. Brand-Miller Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trial. Arch Intern Med, July 24, 2006; 166(14): 1466 - 1475. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Fox, M. J. Pencina, J. B. Meigs, R. S. Vasan, Y. S. Levitzky, and R. B. D'Agostino Sr Trends in the Incidence of Type 2 Diabetes Mellitus From the 1970s to the 1990s: The Framingham Heart Study Circulation, June 27, 2006; 113(25): 2914 - 2918. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Isganaitis and R. H. Lustig Fast Food, Central Nervous System Insulin Resistance, and Obesity Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2451 - 2462. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Choi, D. B. Mount, and A. M. Reginato Pathogenesis of Gout Ann Intern Med, October 4, 2005; 143(7): 499 - 516. [Full Text] [PDF] |
||||
![]() |
A. Drewnowski Concept of a nutritious food: toward a nutrient density score Am. J. Clinical Nutrition, October 1, 2005; 82(4): 721 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Aro, J Ronkainen, N J Talley, T Storskrubb, E Bolling-Sternevald, and L Agreus Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study Gut, October 1, 2005; 54(10): 1377 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wei, D. Wang, and M. J. Pagliassotti Fructose Selectively Modulates c-jun N-Terminal Kinase Activity and Insulin Signaling in Rat Primary Hepatocytes J. Nutr., July 1, 2005; 135(7): 1642 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Gregg, Y. J. Cheng, B. L. Cadwell, G. Imperatore, D. E. Williams, K. M. Flegal, K. M. V. Narayan, and D. F. Williamson Secular Trends in Cardiovascular Disease Risk Factors According to Body Mass Index in US Adults JAMA, April 20, 2005; 293(15): 1868 - 1874. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Walker and B. Walker Why is there disinterest in the appreciation of beneficial dietary recommendations? Am. J. Clinical Nutrition, January 1, 2005; 81(1): 197 - 197. [Full Text] [PDF] |
||||
![]() |
D. J. Jenkins, C. W. Kendall, A. Marchie, and L. S. Augustin Reply to A Walker and B Walker Am. J. Clinical Nutrition, January 1, 2005; 81(1): 197 - 198. [Full Text] [PDF] |
||||
![]() |
G. Bray, S. Nielsen, and B. Popkin Reply to NJ Krilanovich Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1447 - 1448. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |